Insurance & Financial Services
Viewpoints
Filter by:
Expansive SEC Predictive Data Proposal Surprises Broker-Dealers, Advisers & Technology Providers
August 10, 2023 | Alert | By David Adams, Steve Ganis, Kari Harris, Pete Michaels , Talia S. Primor
Read about recently proposed SEC rules for conflicts of interest in the use of predictive data analytics or similar technologies by broker-dealers and investment advisers.
Don’t Text and Trade: Regulators Crack Down on the Use of Improper Communication Channels
June 20, 2023 | Blog | By Pete Michaels , Alyssa C. Scruggs, Yasmin Turco
Registered reps beware: your personal device or messaging account is not the right place to conduct your business affairs, and regulators have made clear that they will not look the other way. In particular, the Financial Industry Regulatory Authority (“FINRA”) and member firms are cracking down on improper communication recordkeeping practices and the use of non-firm applications, including text messages, to communicate with clients.
High Risk, No Reward: SEC’s First Reg BI Enforcement Action
June 21, 2022 | Blog | By Pete Michaels , Michael Pastore, Alyssa C. Scruggs
Brokers beware: Reg BI is dormant no longer. Last week, the Securities and Exchange Commission (“SEC”) filed its first enforcement action alleging violations of Regulation Best Interest” (“Reg BI”), charging Western International Securities Inc. (“Western”) and five of its registered representatives.
Massachusetts Securities Division Lawsuit a Bullseye for Robinhood
April 5, 2022 | Blog | By Pete Michaels , Alyssa C. Scruggs
Online broker-dealers can breathe easily in the Commonwealth of Massachusetts once more, as a Massachusetts court last week found a recent regulation imposing a fiduciary duty standard upon brokerage firms to be unlawful.
FINCEN Seeks the Assistance of Financial Institutions in the Fight Against Environmental Crimes
November 24, 2021 | Blog | By Pete Michaels , Michael Pastore
The Patentability of Blockchain and Cryptocurrency
November 5, 2021 | Video | By Frank Gerratana
Federal Jury Concludes Cryptocurrency Products NOT Securities
November 4, 2021 | Blog | By Sean T. Prosser, Edmund P. Daley
SPACS and Scams: FINRA Announces New Sweep Exams
July 26, 2021 | Blog | By Pete Michaels
Webinar Recording: When the Dust Settles: A Closer Look at the SPAC Boom and Potential Litigation to Follow
June 7, 2021 | Webinar | By Nancy Adams, John Sylvia
Call it a Comeback: The Likely Return of ESG Investing in ERISA Accounts
June 4, 2021 | Blog | By Pete Michaels , Alyssa C. Scruggs
FinCEN Notice Launches Regulatory Process Requiring Covered Domestic and Foreign Companies to Report Beneficial Ownership to U.S. Government
April 5, 2021 | Blog | By Steve Ganis, William F. Weld, Taylor Shepherd
SEC Exam Priorities for 2021 – Focus on Seniors, Reg. BI and Climate Risk (ESG)
March 5, 2021 | Blog
Substantial AML Reforms Enable Regulators to “Follow the Money”
January 21, 2021 | Blog | By Pete Michaels , Cory S. Flashner, Laura E. Martin
ESG Investing in Retirement Accounts: Down But Not Out
November 30, 2020 | Blog | By Pete Michaels , Alyssa C. Scruggs
OCIE Report Uncovers Repeated Compliance Issues At Advisers' Branch Offices
November 20, 2020 | Blog
FINRA Limits Registered Persons from being Beneficiaries or Holding Positions of Trust
November 17, 2020 | Blog
SEC Commissioner Considers Future ESG Investment Regulation
November 17, 2020 | Blog
National Adjudicatory Council Revises FINRA Sanction Guidelines
November 2, 2020 | Blog
Wither Enforcement? CFPB Reorganization Signals Big Changes
October 27, 2020 | Blog
You Can’t Always Get What You Want: The End of ESG Investing in ERISA Accounts
October 26, 2020 | Blog | By Pete Michaels , Alyssa C. Scruggs
Explore Other Viewpoints:
- AI: The Washington Report
- Antitrust
- Appellate
- Arbitration, Mediation & Alternate Dispute Resolution
- Artificial Intelligence
- Awards
- Bankruptcy & Restructuring
- California Land Use
- Cannabis
- Class Action
- Complex Commercial Litigation
- Construction
- Consumer Product Safety
- Corporate Governance (ESG)
- Cross-Border Asset Recovery
- Debt Financing
- Direct Investing (M&A)
- Diversity
- EB-5 Financing
- Education & Nonprofits
- Employment
- Energy & Sustainability
- Environmental (ESG)
- Environmental Enforcement Defense
- Environmental Law
- Environmental, Social, and Corporate Governance (ESG)
- FDA Regulatory
- False Claims Act
- Federal Circuit Appeals
- Financial Institution Litigation
- Government Law
- Growth Equity
- Health Care
- Health Care Compliance, Fraud and Abuse, & Regulatory Counseling
- Health Care Enforcement & Investigations
- Health Care Transactions
- Health Information Privacy & Security
- IP Due Diligence
- IPRs & Other Post Grant Proceedings
- Immigration
- Impacts of a New US Administration
- Insolvency & Creditor Rights Litigation
- Institutional Investor Class Action Recovery
- Insurance & Financial Services
- Insurance Consulting & Risk Management
- Insurance and Reinsurance Problem-Solving & Dispute Resolution
- Intellectual Property
- Investment Funds
- Israel
- Licensing & Technology Transactions
- Life Sciences
- Litigation & Investigations
- M&A Litigation
- ML Strategies
- Medicare, Medicaid and Commercial Coverage & Reimbursement
- Mergers & Acquisitions
- Patent Litigation
- Patent Prosecution & Strategic Counseling
- Pharmacy Benefits and PBM Contracting
- Portfolio Companies
- Privacy & Cybersecurity
- Private Client
- Private Equity
- Pro Bono
- Probate & Fiduciary Litigation
- Products Liability & Complex Tort
- Projects & Infrastructure
- Public Finance
- Real Estate Litigation
- Real Estate Transactions
- Real Estate, Construction & Infrastructure
- Retail & Consumer Products
- Securities & Capital Markets
- Securities Litigation
- Social (ESG)
- Special Purpose Acquisition Company (SPACs)
- Sports & Entertainment
- State Attorneys General
- Strategic IP Monetization & Licensing
- Tax
- Technology
- Technology, Communications & Media
- Technology, Communications & Media Litigation
- Trade Secrets
- Trademark & Copyright
- Trademark Litigation
- Value-Based Care
- Venture Capital & Emerging Companies
- White Collar Defense & Government Investigations
- Women's Health and Technology